HAYWARD, Calif., Oct. 27 /PRNewswire-FirstCall/ -- Aradigm Corporation announced today that Dr. Bryan Lawlis, the company’s President and Chief Executive Officer, will provide a company overview at Rodman and Renshaw’s 7th Annual Techvest Conference on November 8th at New York’s Plaza Hotel.
This event will webcast live and may be accessed by visiting the Investors section of www.aradigm.com.
The presentation will be delivered at 11:55 am Eastern Time on Tuesday, November 8, 2005 and the event will be archived on the company website for 30 days.
Aradigm develops non-invasive delivery systems to enable patients to comfortably self-administer biopharmaceuticals and small molecules. The company’s advanced AERx(R) pulmonary and Intraject(R) needle-free delivery technologies offer rapid delivery solutions for liquid drug formulations. Current development programs focus on neurological disorders, heart disease, respiratory conditions, smoking cessation, and diabetes. More information about Aradigm can be found at www.aradigm.com.
NOTE: AERx, and Intraject are registered trademarks of Aradigm Corporation. Contact: Christopher Keenan or Joe Dorame Aradigm RCG Capital Markets Group, Inc. 510-265-9370 602-889-9696
Aradigm Corporation
CONTACT: Christopher Keenan of Aradigm, +1-510-265-9370; or Joe Dorame ofRCG Capital Markets Group, Inc., +1-602-889-9696
Web site: http://www.aradigm.com/
